Subcellular distribution of protein phosphatases and abnormally phosphorylated τ in the temporal cortex from Alzheimer's disease and control brains

被引:0
|
作者
J.-J. Pei
C.-X. Gong
K. Iqbal
I. Grundke-Iqbal
Q. L. Wu
B. Winblad
R. F. Cowburn
机构
[1] Karolinska Institute,
[2] Department of Clinical Neuroscience and Family Medicine,undefined
[3] Section for Geriatric Medicine,undefined
[4] Novum,undefined
[5] KFC,undefined
[6] Huddinge,undefined
[7] Sweden,undefined
[8] NYS Institute for Basic Research in Developmental Disabilities,undefined
[9] Staten Island,undefined
[10] NY,undefined
[11] U.S.A.,undefined
来源
Journal of Neural Transmission | 1998年 / 105卷
关键词
Keywords: Protein phosphatases; AD P-tau; subcellular fractions; indirect enzyme-linked immunosorbent assay (ELISA); Alzheimer's disease.;
D O I
暂无
中图分类号
学科分类号
摘要
Microtubule-associated protein tau is abnormally hyperphosphorylated in the brain of patients with Alzheimer's disease (AD). In vitro studies have shown that protein phosphatases PP-2A and PP-2B can convert Alzheimer like tau to its normal state and that the activities of PP-1, PP-2A, and phosphotyrosyl-protein phosphatase (PTP) are reduced in AD brain. However, to have a direct effect on the regulation of phosphorylation on tau, these enzymes have to exist in neurons. Using specific polyclonal antibodies the levels of protein phosphatases PP-1, PP-2A, and PP-2B were determined by indirect ELISA in superior temporal cortical gray matter of AD and control brains. The protein levels of PP-2A and PP-2B were significantly increased in postsynaptosomal supernatant 2 (S2) of the AD group, and this alteration showed a significant linear correlation with levels of hyperphosphorylated tau. PP-1 and PTP-1B levels were not significantly changed in any of the AD fractions. Because of the large variation from case to case, the activity levels of none of the phosphatases investigated were significantly different between the AD and control groups. However, the PP-2B specific activity (activity/protein) showed a significant linear inverse correlation with hyperphosphorylated tau. These studies suggest that any attempt by the AD brain to compensate for the decreased tau phosphatase activity remains unsuccessful and that the decrease in phosphatase activity might contribute to increased levels of abnormally phosphorylated tau.
引用
收藏
页码:69 / 84
页数:15
相关论文
共 50 条
  • [21] Assessment of protein kinase C mRNA levels in Alzheimer's disease brains
    Chachin, M
    Shimohama, S
    Kunugi, YU
    Taniguchi, T
    JAPANESE JOURNAL OF PHARMACOLOGY, 1996, 71 (02) : 175 - 177
  • [22] Phospholipase pathway in Alzheimer's disease brains:: decrease in Gαi in dorsolateral prefrontal cortex
    Young, RA
    Talbot, K
    Gao, ZY
    Trojanowski, JQ
    Wolf, BA
    MOLECULAR BRAIN RESEARCH, 1999, 66 (1-2): : 188 - 190
  • [23] Tau protein phosphatases in Alzheimer's disease: The leading role of PP2A
    Martin, Ludovic
    Latypova, Xenia
    Wilson, Cornelia M.
    Magnaudeix, Amandine
    Perrin, Marie-Laure
    Terro, Faraj
    AGEING RESEARCH REVIEWS, 2013, 12 (01) : 39 - 49
  • [24] Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects
    Naylor, Jennifer C.
    Kilts, Jason D.
    Hulette, Christine M.
    Steffens, David C.
    Blazer, Dan G.
    Ervin, John F.
    Strauss, Jennifer L.
    Allen, Trina B.
    Massing, Mark W.
    Payne, Victoria M.
    Youssef, Nagy A.
    Shampine, Lawrence J.
    Marx, Christine E.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2010, 1801 (08): : 951 - 959
  • [25] Lipofuscin and Aβ42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains
    D'Andrea, MR
    Nagele, RG
    Gumula, NA
    Reiser, PA
    Polkovitch, DA
    Hertzog, BM
    Andrade-Gordon, P
    NEUROSCIENCE LETTERS, 2002, 323 (01) : 45 - 49
  • [26] Altered subcellular distribution of transcriptional regulators in response to Aβ peptide and during Alzheimer's disease
    Jordan-Sciutto, K
    Rhodes, J
    Bowser, R
    MECHANISMS OF AGEING AND DEVELOPMENT, 2001, 123 (01) : 11 - 20
  • [27] Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients
    Battaini, F
    Pascale, A
    Lucchi, L
    Pasinetti, GM
    Govoni, S
    EXPERIMENTAL NEUROLOGY, 1999, 159 (02) : 559 - 564
  • [28] Gene expression of ND4, a subunit of complex I of oxidative phosphorylation in mitochondria, is decreased in temporal cortex of brains of Alzheimer's disease patients
    Fukuyama, R
    Hatanpaa, K
    Rapoport, SI
    Chandrasekaran, K
    BRAIN RESEARCH, 1996, 713 (1-2) : 290 - 293
  • [29] CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
    Buerger, Katharina
    Ewers, Michael
    Pirttila, Tuula
    Zinkowski, Raymond
    Alafuzoff, Irina
    Teipel, Stefan J.
    DeBernardis, John
    Kerkman, Daniel
    McCulloch, Cheryl
    Soininen, Hilkka
    Hampel, Harald
    BRAIN, 2006, 129 : 3035 - 3041
  • [30] Isolation of synaptic terminals from Alzheimer's disease cortex
    Sokolow, Sophie
    Henkins, Kristen M.
    Williams, Iris A.
    Vinters, Harry V.
    Schmid, Ingrid
    Cole, Gregory M.
    Gylys, Karen H.
    CYTOMETRY PART A, 2012, 81A (03) : 248 - +